Jefferies Discusses Array BioPharma (ARRY) After Detailed Selumetinib Ph2 Data in NSCLC
Go back to Jefferies Discusses Array BioPharma (ARRY) After Detailed Selumetinib Ph2 Data in NSCLC| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 4.69 -0.02 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.71 | 52 Week High | $7.27 | |||
| Open | $4.75 | 52 Week Low | $2.39 | |||
| Day High | $4.80 | P/E | N/A | |||
| Day Low | $4.63 | EPS | $-0.61 | |||
| Volume | 8,283,330 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,179,791 | |||||
